EUVIMEDEUVIMED entdecken
Crossref

Identification and characterization of the rat in-vivo and in-vitro metabolites of tazemetostat using LC-QTOF-MS

Niraj Rajput, Tarang Jadav, Pinaki Sengupta

Food and Chemical Toxicology · 2024

DOI: 10.1016/j.fct.2024.114785 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Food and Chemical Toxicology, 2024. Verfasst von Niraj Rajput und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research-Ahmedabad (NIPER-A), An Institute of National Impo…. Hauptthemen laut MEDLINE: Chromatography, Liquid, Tandem Mass Spectrometry. Die Arbeit nennt 25 Literaturangaben. Gefördert von: Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India, National Institute of Pharmaceutical Education and Research, Raebareli.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In drug discovery, metabolite profiling unveils biotransformation pathways and potential toxicant formation, guiding selection of candidates with optimal pharmacokinetics and safety profiles. Tazemetostat (TAZ) is employed in treating locally advanced or metastatic epithelioid sarcoma. Identification of drug metabolites are of significant importance in improving safety, efficacy and reduced toxicity of drugs. The current study aimed to investigate the comprehensive metabolic fate of TAZ using different in vivo (rat) and in vitro (RLM, HLM, HS9) models. For in vivo studies, drug was orally administered to Sprague-Dawley rats with subsequent analysis of plasma, feces and urine samples. A total of 21 new metabolites were detected across various matrices and were separated on Phenomenex kinetex C18 (2.5 μm; 150 × 4.6 mm) column using acetonitrile and 0.1% formic acid in water as mobile phase. LC-QTOF-MS/MS and NMR techniques were employed to identify and characterize the metabolites from extracted samples. The major metabolic routes found in biotransformation of TAZ were hydroxylation, N-dealkylation, N-oxidation, hydrogenation, hydrolysis and N-acetylation. In silico toxicity revealed potential immunotoxicity for TAZ and few of its metabolites. This research article is the first time to discuss the complete metabolite profiling including identification and characterization of TAZ metabolites as well as its biotransformation mechanism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chromatography, LiquidTandem Mass SpectrometryAnimalsHumansMaleRatsBiotransformationFecesHydroxylationMicrosomes, LiverRats, Sprague-Dawley

Stichwörter der Autor:innen

APCI-MSIn silico toxicity studiesLC-QTOF-MS/MSMetabolite identification and characterizationNMRTazemetostat

Autor:innen und Institutionen

  • Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research-Ahmedabad (NIPER-A), An Institute of National Importance, Government of India, Opp. Airforce Station, Palaj, Gandhinagar…

Förderung

  • Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India
  • National Institute of Pharmaceutical Education and Research, Raebareli

Zitieren

APA

Rajput, N., Jadav, T., & Sengupta, P. (2024). Identification and characterization of the rat in-vivo and in-vitro metabolites of tazemetostat using LC-QTOF-MS. Food and Chemical Toxicology. https://doi.org/10.1016/j.fct.2024.114785

Vancouver

Rajput N, Jadav T, Sengupta P. Identification and characterization of the rat in-vivo and in-vitro metabolites of tazemetostat using LC-QTOF-MS. Food and Chemical Toxicology. 2024. doi:10.1016/j.fct.2024.114785

BibTeX
@article{Rajput2024,
  author = {Rajput, Niraj and Jadav, Tarang and Sengupta, Pinaki},
  title = {Identification and characterization of the rat in-vivo and in-vitro metabolites of tazemetostat using LC-QTOF-MS},
  journal = {Food and Chemical Toxicology},
  year = {2024},
  doi = {10.1016/j.fct.2024.114785}
}
Kostenlos starten →